Kentucky's attorney general has sued a drug maker, accusing the company of misleading consumers about a diabetes drug in a state plagued by high rates of the disease.
The suit claims that GlaxoSmithKline overstated the effectiveness of the prescription drug Avandia and hid its risks.
Attorney General Jack Conway says the drug maker claimed that Avandia could reduce cardiovascular risks faced by diabetics. The lawsuit claims the drug actually increases those cardiovascular risks.
The suit filed this week in Franklin County Circuit Court in Frankfort accuses the company of violating the state's Consumer Protection Act. The suit seeks an injunction against the company and civil penalties up to $10,000 per violation.
GSK spokesman Kevin Colgan says the company acted properly in studying and marketing the drug.
